Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

NCT01938248 ·Status: COMPLETED ·Phase: PHASE4

Long-term Safety in Atrial Fibrillation Patients

NCT00645853 ·Status: COMPLETED ·Phase: PHASE2

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

NCT01642134 ·Status: COMPLETED ·Phase: PHASE4

Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy

NCT02921126 ·Status: COMPLETED

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI?

NCT04436978 ·Status: RECRUITING ·Phase: PHASE4

Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation

NCT02565693 ·Status: COMPLETED ·Phase: PHASE2

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NCT02007655 ·Status: COMPLETED

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention

NCT01830543 ·Status: COMPLETED ·Phase: PHASE3

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

NCT00412984 ·Status: COMPLETED ·Phase: PHASE3

Apixaban Dose Reduction in Patients With Elevated Drug Levels

NCT02809469 ·Status: UNKNOWN ·Phase: PHASE2

Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation

NCT02181361 ·Status: COMPLETED

Treatment Pattern of Oral Anticoagulants (OAC) in Japan

NCT02982863 ·Status: COMPLETED

Prospective Real-world Registry Describing Treatment Regimens

NCT03942913 ·Status: UNKNOWN

A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Elderly Participants With Non-Valvular Atrial Fibrillation

NCT05232643 ·Status: RECRUITING

PRescriptiOn PattERns Of Oral Anticoagulants

NCT02366338 ·Status: COMPLETED

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation

NCT03839355 ·Status: TERMINATED ·Phase: PHASE3

Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA)

NCT00623779 ·Status: COMPLETED ·Phase: PHASE2

Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care

NCT04099238 ·Status: COMPLETED

AERIAL Trial: Antiplatelet Therapy in Heart Transplantation

NCT04770012 ·Status: RECRUITING ·Phase: PHASE3

Antithrombotic Triple Therapy in Humans

NCT01812200 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation

NCT02082548 ·Status: COMPLETED ·Phase: NA

Replication of the ROCKET-AF Anticoagulant Trial in Healthcare Claims Data

NCT04593056 ·Status: COMPLETED

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

NCT02100228 ·Status: COMPLETED ·Phase: PHASE4

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

NCT02415400 ·Status: COMPLETED ·Phase: PHASE4

Adherence to New Oral Anticoagulation Therapy in Turkey

NCT02480920 ·Status: COMPLETED